Telomerase inhibitor (investigational)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Telomerase inhibitor (investigational), covering 2015-10-27 to 2015-10-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study Inhibiting Telomerase to Reverse Trastuzumab Resistance in HER2+ Breast Cancer [Phase 1]